434 related articles for article (PubMed ID: 25401976)
41. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
[TBL] [Abstract][Full Text] [Related]
42. Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.
Nikkilä J; Kumar R; Campbell J; Brandsma I; Pemberton HN; Wallberg F; Nagy K; Scheer I; Vertessy BG; Serebrenik AA; Monni V; Harris RS; Pettitt SJ; Ashworth A; Lord CJ
Br J Cancer; 2017 Jun; 117(1):113-123. PubMed ID: 28535155
[TBL] [Abstract][Full Text] [Related]
43. Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia.
Hayashi A; Yashima K; Takeda Y; Sasaki S; Kawaguchi K; Harada K; Murawaki Y; Ito H
J Gastroenterol Hepatol; 2012 Nov; 27(11):1752-8. PubMed ID: 22742976
[TBL] [Abstract][Full Text] [Related]
44. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
Cavazzoni A; Petronini PG; Galetti M; Roz L; Andriani F; Carbognani P; Rusca M; Fumarola C; Alfieri R; Sozzi G
Oncogene; 2004 Nov; 23(52):8439-46. PubMed ID: 15361849
[TBL] [Abstract][Full Text] [Related]
45. Polyomavirus T Antigen Induces
Starrett GJ; Serebrenik AA; Roelofs PA; McCann JL; Verhalen B; Jarvis MC; Stewart TA; Law EK; Krupp A; Jiang M; Martens JWM; Cahir-McFarland E; Span PN; Harris RS
mBio; 2019 Feb; 10(1):. PubMed ID: 30723127
[TBL] [Abstract][Full Text] [Related]
46. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
Cescon DW; Haibe-Kains B; Mak TW
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2841-6. PubMed ID: 25730878
[TBL] [Abstract][Full Text] [Related]
47. Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions.
Pichiorri F; Okumura H; Nakamura T; Garrison PN; Gasparini P; Suh SS; Druck T; McCorkell KA; Barnes LD; Croce CM; Huebner K
J Biol Chem; 2009 Jan; 284(2):1040-9. PubMed ID: 19004824
[TBL] [Abstract][Full Text] [Related]
48. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.
Middlebrooks CD; Banday AR; Matsuda K; Udquim KI; Onabajo OO; Paquin A; Figueroa JD; Zhu B; Koutros S; Kubo M; Shuin T; Freedman ND; Kogevinas M; Malats N; Chanock SJ; Garcia-Closas M; Silverman DT; Rothman N; Prokunina-Olsson L
Nat Genet; 2016 Nov; 48(11):1330-1338. PubMed ID: 27643540
[TBL] [Abstract][Full Text] [Related]
49. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S
Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491
[TBL] [Abstract][Full Text] [Related]
50. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
[TBL] [Abstract][Full Text] [Related]
51. microRNA-143 protects cells from DNA damage-induced killing by downregulating FHIT expression.
Lin YX; Yu F; Gao N; Sheng JP; Qiu JZ; Hu BC
Cancer Biother Radiopharm; 2011 Jun; 26(3):365-72. PubMed ID: 21711110
[TBL] [Abstract][Full Text] [Related]
52. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
[TBL] [Abstract][Full Text] [Related]
53. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.
Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K
Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174
[TBL] [Abstract][Full Text] [Related]
54. Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.
Miuma S; Saldivar JC; Karras JR; Waters CE; Paisie CA; Wang Y; Jin V; Sun J; Druck T; Zhang J; Huebner K
PLoS One; 2013; 8(11):e80730. PubMed ID: 24244712
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract][Full Text] [Related]
56. Genetic inhibitors of APOBEC3B-induced mutagenesis.
Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Cordero C; Bray N; Harcy V; Vyas RK; Mitchell D; Lobachev K; Roberts SA
Genome Res; 2023 Sep; 33(9):1568-1581. PubMed ID: 37532520
[TBL] [Abstract][Full Text] [Related]
57. Aberrations in the fragile histidine triad(FHIT) gene may be involved in lung carcinogenesis in patients with chronic pulmonary tuberculosis.
Song L; Yan W; Deng M; Song S; Zhang J; Zhao T
Tumour Biol; 2004; 25(5-6):270-5. PubMed ID: 15627891
[TBL] [Abstract][Full Text] [Related]
58. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
59. Do FHIT gene alterations play a role in human solid tumors?
Silveira Zavalhia L; Weber Medeiros A; Oliveira Silva A; Vial Roehe A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e214-e223. PubMed ID: 29516675
[TBL] [Abstract][Full Text] [Related]
60. B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers.
Chou WC; Chen WT; Hsiung CN; Hu LY; Yu JC; Hsu HM; Shen CY
Sci Rep; 2017 Mar; 7():44089. PubMed ID: 28276478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
